Results 1 to 10 of about 6,804 (189)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds [PDF]

Journal of Clinical Medicine, 2021
Epistaxis is the most prevalent clinical symptom in Hereditary Haemorrhagic Telangiectasia (HHT), causing anaemia and decreasing the quality of life (QOL). Since 2013, in Hospital Universitario Fundación Alcorcón, more than 150 HHT patients have been treated by nose sclerotherapy on demand.
Sol Marcos, Luisa M Botella, Virginia Albinana   +2 more
exaly   +4 more sources

Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant bleeding disorder. The incidence of venous thromboembolisms among HHT patients is significantly greater than the general population. However, providing therapeutic anticoagulation in patients with an increased propensity for bleeding creates a clinical dilemma.
Carfagnini C, Kandula M.
europepmc   +2 more sources

Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT

Journal of Clinical Medicine, 2023
Background: Hereditary Hemorrhagic Telangiectasia (HHT) is a vascular autosomically inherited rare disease. Epistaxis (nose bleeds) is the most common symptom in HHT, leading to anemia and affecting patient’s quality of life. In addition to epistaxis, gastrointestinal bleeding (GI), more often at older ages, may lead to severe anemia and need for blood
JOSÉ Luis Patier, Sol Marcos, Vicente Gomez Del Olmo   +2 more
exaly   +5 more sources

Characterizing Self‐Reported Daily Diary Epistaxis Measures in Hereditary Hemorrhagic Telangiectasia [PDF]

Laryngoscope Investigative Otolaryngology
Objectives To characterize a proposed clinical trial outcome measure of weekly cumulative bleeding duration from daily nosebleed diaries, termed PRO‐CB (patient‐reported outcome of cumulative bleeding). We also assessed cumulative weekly gushing bleeding
C. M. Tarulli, X. Ma, A. M. Bayoumi, A. Patel, N. T. Vozoris, J. M. Lee, M. E. Faughnan   +6 more
doaj   +2 more sources

HHT and gastric telangiectasia [PDF]

QJM, 2015
A 58-year-old Taiwanese married male presented to our emergency department with progressive dizziness and generalized weakness for 1 week. His blood pressure was 138/91 mmHg and heart rate was 74 bpm. He stated that nosebleeds occurred off and on for more than 20 years, and he had been diagnosed pulmonary arteriovenous malformation (AVM) and received ...
P-L, Lay, T-Y, Huang, C-H, Hsu
openaire   +2 more sources

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Hepatology, EarlyView., 2022
Hepatic endothelial Alk1 signaling protects from development of vascular malformations while maintaining organ‐specific endothelial differentiation and angiocrine portmanteau of the names Wingless and Int‐1 signaling. Abstract Background and Aims In hereditary hemorrhagic telangiectasia (HHT), severe liver vascular malformations are associated with ...
Christian David Schmid, Victor Olsavszky, Manuel Reinhart, Vanessa Weyer, Felix A. Trogisch, Carsten Sticht, Manuel Winkler, Sina W. Kürschner, Johannes Hoffmann, Roxana Ola, Theresa Staniczek, Joerg Heineke, Beate K. Straub, Jens Mittler, Kai Schledzewski, Peter ten Dijke, Karsten Richter, Steven Dooley, Cyrill Géraud, Sergij Goerdt, Philipp‐Sebastian Koch   +20 more
wiley   +1 more source

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence [PDF]

Journal of Clinical Medicine, 2020
Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disease, is characterized by telangiectases and arteriovenous malformations (AVMs). Untreated AVMs, especially in the lungs—pulmonary AVMs (PAVMs)—can result in morbidity with a decreased life expectancy. We have investigated whether HHT patients, systematically screened for HHT-related
Els M. de Gussem, Steven Kroon, Anna E. Hosman, Johannes C. Kelder, Martijn C. Post, Repke J. Snijder, Johannes J. Mager   +6 more
openaire   +4 more sources

Gender differences in hereditary hemorrhagic telangiectasia severity

Orphanet Journal of Rare Diseases, 2020
Background Gender differences in organ involvement and clinical severity have been poorly described in hereditary hemorrhagic telangiectasia (HHT). The aim of this study was to describe differences in the severity of HHT manifestations according to ...
J. M. Mora-Luján, A. Iriarte, E. Alba, M. A. Sánchez-Corral, P. Cerdà, F. Cruellas, Q. Ordi, X. Corbella, J. Ribas, J. Castellote, A. Riera-Mestre   +10 more
doaj   +1 more source

Application of Improved VMD-HT in Power Quality Disturbance Detection [PDF]

Zhengzhou Daxue xuebao. Gongxue ban, 2021
To solve the problems of low power quality disturbance detection accuracy and weak anti-interference, a VMD-HT method based on energy convergence factor and PSO optimization was proposed in this paper.
LIAO Xiaohui, CHEN Chuanchuan
doaj   +1 more source

HHT-based audio coding [PDF]

Signal, Image and Video Processing, 2013
In this paper, a new audio coding scheme combining the Hilbert transform and the empirical mode decomposition (EMD) is introduced. Based on the EMD, the coding is fully a data-driven approach. Audio signal is first decomposed adaptively, by EMD, into intrinsic oscillatory components called intrinsic mode functions (IMFs).
Kais Khaldi, Abdel-Ouahab Boudraa, Bruno Torrésani, Thierry Chonavel   +3 more
openaire   +3 more sources